Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases. (2018)
Attributed to:
MICA: BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2017-211937
PubMed Identifier: 28866648
Publication URI: http://europepmc.org/abstract/MED/28866648
Type: Journal Article/Review
Volume: 77
Parent Publication: Annals of the rheumatic diseases
Issue: 2
ISSN: 0003-4967